Risk Management Submissions Need To Be Better Organized, FDA Says
Executive Summary
Industry submissions of risk management plans are not following FDA's guidance for the organization of the materials, agency officials said during a recent webinar sponsored by the Drug Information Association
You may also be interested in...
FDA Reform Bill Will Keep Firms Scrambling To Stay Ahead On Safety Issues
Pharmaceutical companies need to immediately begin assessing whether their drugs are subject to the risk evaluation and mitigation strategies provisions of the FDA Amendments Act, participants were warned during a Food and Drug Law Institute audioconference on the new law, Oct. 4
FDA Reform Bill Will Keep Firms Scrambling To Stay Ahead On Safety Issues
Pharmaceutical companies need to immediately begin assessing whether their drugs are subject to the risk evaluation and mitigation strategies provisions of the FDA Amendments Act, participants were warned during a Food and Drug Law Institute audioconference on the new law, Oct. 4
FDA Putting System In Place For RiskMAP Evaluation And Management
FDA is trying to provide clarity on its risk management plan program by creating a Web site that will serve as a central source of risk management plan information